Download presentation
Presentation is loading. Please wait.
1
eHIVQUAL 2016 Overview February 15, 2017
5/15/2018 1:30 AM eHIVQUAL 2016 Overview February 15, 2017 Christopher Wells Data Analyst NYSDOH AIDS Institute © 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries. The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
2
A brief history of eHIVQUAL
Application for reviewing quality of care for HIV+ patients in NYS Retrospective calendar-year reviews Microsoft Access versions Migration to the web in 2010 for 2009 review Secure site Registered users Trend toward including fewer indicators but more patients (EtE and cascade of care focus) Increased use of data import features to accommodate this (information for those partnering with Azara will be provided at the end of this presentation)
3
Where eHIVQUAL fits this year
In addition to eHIVQUAL, the 2016 quality of care review will include: Organizational cascades (underway) Tobacco cessation campaign (pending) Stigma survey (pending)
4
Why both eHIVQUAL and Cascade?
Linkage data not captured in eHIVQUAL Cascades can be creative and include elements beyond required measures Two aspects of capacity building Querying patient-level data Reporting findings and conducting QI work eHIVQUAL will serve as a “reality check” on the cascades, but submission of cascades can occur before eHIVQUAL data are approved
5
Scope of review: open and active patients
Definitions: Open patients: All patients, regardless of age, with a known diagnosis of HIV who received any clinical service(s) in the organization during the review period. Includes patients seen for routine, urgent, emergent and/or inpatient care. Active patients: All patients who were enrolled in your HIV program as of the end of 2016 and who were seen for at least one clinical visit in 2016. Non-active patients: All other patients in your open patient caseload. Includes patients who, as of the end of the year, were deceased, incarcerated, in care elsewhere or of unknown care status.
6
Scope of review: open and active patients (continued)
Open caseload: HIV+ patients who “touched the facility” in 2016.
7
Scope of review: open and active patients (continued)
Active caseload: HIV+ patients who received services in the HIV program and remained enrolled as of 12/31/16.
8
Scope of review: open and active patients (continued)
Required to enter/upload all “open patients” but may sample active patients for STI indicators Implications for different types of organizations The ratio of open to active patients may vary depending on variety of services offered Networks: Active patients attributed to site of enrollment Inactive patients entered wherever seen most often Ratio of open to active patients will vary
9
Care-status categories and required data
Active patients Non-active patients Deceased Incarcerated In care elsewhere Unknown care status
10
Care-status categories and required data (continued)
STI data not required
11
Care-status categories and required data (continued)
STI data not required VLS, ART and most of the patient characteristics data are not required
12
Care-status categories and required data (continued)
STI data not required
13
Care-status categories and required data: complete chart
STI data not required VLS, ART and most patient characteristics data are not required
14
Care-status categories and required data: summary table
15
Indicators Antiretroviral therapy
Suppressed on last VL of review period Syphilis treatment No screening question Any treatment v. appropriate treatment Gonorrhea testing and treatment Extra-genital testing for MSM/MtF (pharyngeal and rectal) Chlamydia testing and treatment Extra-genital testing for MSM/MtF (rectal)
16
Other data elements Patient identifying information Care status
Name DOB MRN Sex Race/ethnicity Exposure risk Diagnosed during review period Care status Insurance status at last status check Housing status
17
Options for entering the data
Manual data entry (form pending) Can use previously entered information in some cases Some data elements are not required for some patients Import templates (data dictionary pending) Data must match specifications exactly Some elements may be difficult to query from medical records systems No typing required! Hybrid approaches
18
Guidance and support: documentation
eHIVQUAL documentation Indicator guide and algorithms (posted) User guide (pending) Sampling methodology (pending) Import instructions (pending) Webinars (announcement pending) Importing data Running reports Validating and submitting data
19
Guidance and support: obtaining further help
Group account Role of principal AI staff Chris Wells, Data Analyst Daniel Belanger, Director, NYS Quality of Care Program Role of QI coaches (including other AI staff) Steven Sawicki Susan Weigl Nanette Brey Magnani Nova West Clemens Steinbock
20
Timeline Registration: 2nd half of February (ongoing support as needed) Application launch: late February Webinars: March Data entry and import options Reports Validation and submission Submission deadline: extended to 4/30/17 But, cascade deadline remains 3/31/17
21
This concludes the main portion of our presentation….
QUESTIONS?
22
A word to our colleagues who are working with Azara Healthcare
At the request of CHCANYS, Azara Healthcare, a data analytics company based in Burlington, MA, has contracted with 18 FQHCs to facilitate extraction of data for the eHIVQUAL review (not cascades) Two extracts to be produced by Azara Initial: 3/1/17 Final: 3/31/17 Now is the time to review EHR mappings with Azara (sample extracts and CPCI reports) FQHCs will need to specify which patients are active, deceased, incarcerated or in care elsewhere We will be pilot testing the data handling processes for this as soon as possible
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.